Eastern CT Hematology and Oncology Associates — Norwich, Connecticut

Eastern CT Hematology and Oncology Associates is a clinical research site located in Norwich, Connecticut, United States 06360.

Crixeo Clinical Trials Trust Score: 18/100 (FAILING). This profile has not yet been claimed by the site owner.

Eastern CT Hematology and Oncology Associates has participated in 12 clinical trials with 3 currently active.

Therapeutic areas: Advanced Non-Small Cell Lung Cancer, Carcinoma, Transitional Cell, Urinary Bladder Neoplasms.

Sponsors: Regeneron Pharmaceuticals, Astellas Pharma Global Development, Inc., Mitra RxDx, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Norwich

Browse all research sites in Connecticut · View every site in Norwich

Sponsor Feasibility Report

Trust Score: 18/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Eastern CT Hematology and Oncology Associates?

Eastern CT Hematology and Oncology Associates has a Crixeo Trust Score of 18/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Eastern CT Hematology and Oncology Associates conducted?

Eastern CT Hematology and Oncology Associates has 12 clinical trials on record, with 3 currently active. Their work covers Advanced Non-Small Cell Lung Cancer, Carcinoma, Transitional Cell, Urinary Bladder Neoplasms.

Is Eastern CT Hematology and Oncology Associates accredited by Crixeo Clinical Trials?

Eastern CT Hematology and Oncology Associates has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Eastern CT Hematology and Oncology Associates?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.